Pharvaris (PHVS) Short Interest Ratio & Short Volume $23.36 +0.36 (+1.54%) As of 03:09 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Pharvaris Short Interest DataPharvaris (PHVS) has a short interest of 446,000 shares, representing 1.98% of the float (the number of shares available for trading by the public). This marks a -45.59% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.3, indicating that it would take 4.3 days of the average trading volume of 80,391 shares to cover all short positions.Current Short Interest446,000 sharesPrevious Short Interest819,700 sharesChange Vs. Previous Month-45.59%Dollar Volume Sold Short$8.87 millionShort Interest Ratio4.3 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares52,290,000 sharesFloat Size22,560,000 sharesShort Percent of Float1.98%Today's Trading Volume113,305 sharesAverage Trading Volume80,391 sharesToday's Volume Vs. Average141% Short Selling Pharvaris? Sign up to receive the latest short interest report for Pharvaris and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPHVS Short Interest Over TimePHVS Days to Cover Over TimePHVS Percentage of Float Shorted Over Time Pharvaris Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025446,000 shares $8.87 million -45.6%2.0%4.3 $19.88 7/15/2025819,700 shares $18.84 million +4.4%4.7%7.8 $22.99 6/30/2025785,400 shares $13.82 million +0.1%4.5%11.6 $17.60 6/15/2025784,900 shares $13.11 million +8.7%4.5%11.8 $16.70 5/31/2025722,100 shares $11.94 million +14.6%4.1%10.5 $16.53 5/15/2025630,100 shares $10.02 million -3.1%3.6%9.9 $15.91 4/30/2025650,200 shares $12.02 million +16.6%3.7%10.6 $18.48 4/15/2025557,700 shares $7.77 million -5.6%3.2%11.7 $13.94 3/31/2025590,700 shares $9.27 million +2.3%3.4%13.9 $15.70 3/15/2025577,700 shares $9.63 million +18.6%3.4%12.7 $16.67 Get the Latest News and Ratings for PHVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharvaris and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025487,300 shares $7.75 million +24.7%2.8%8.8 $15.90 2/15/2025390,900 shares $6.75 million +25.7%2.3%6 $17.27 1/31/2025311,100 shares $5.48 million +99.4%1.8%4.8 $17.60 1/15/2025156,000 shares $2.60 million -4.8%0.9%2.2 $16.65 12/31/2024163,900 shares $3.14 million +7.8%1.0%2 $19.17 12/15/2024152,100 shares $2.80 million -24.8%0.9%1.8 $18.40 11/30/2024202,200 shares $4.43 million +10.3%1.2%1.9 $21.90 11/15/2024183,300 shares $3.73 million +33.5%1.1%1.7 $20.35 10/31/2024137,300 shares $3.41 million +4.2%0.8%1.3 $24.87 10/15/2024131,800 shares $2.74 million -83.8%0.7%1.3 $20.82 9/30/2024813,000 shares $15.06 million +26.5%4.5%9.2 $18.52 9/15/2024642,800 shares $13.45 million +254.4%3.6%7.6 $20.92 8/31/2024181,400 shares $3.27 million +39.5%1.0%2.3 $18.00 8/15/2024130,000 shares $2.49 million +3.3%0.7%2.2 $19.19 7/31/2024125,800 shares $2.16 million +1.4%0.7%2.2 $17.14 7/15/2024124,100 shares $2.22 million -9.8%0.7%2 $17.86 6/30/2024137,500 shares $2.59 million +15.0%0.7%1.9 $18.80 6/15/2024119,600 shares $2.24 million +3.9%0.6%1.7 $18.76 5/31/2024115,100 shares $2.18 million -7.8%0.6%1.8 $18.96 5/15/2024124,800 shares $2.76 million +5.1%0.7%1.7 $22.10 4/30/2024118,700 shares $2.92 million +31.3%0.3%1.5 $24.59 4/15/202490,400 shares $1.82 million +813.1%0.9%0.9 $20.15 3/31/20249,900 shares $228.79 thousand -33.6%0.1%0.1 $23.11 3/15/202414,900 shares $347.92 thousand -85.3%0.2%0.1 $23.35 2/29/2024101,600 shares $2.33 million -6.2%0.6%0.6 $22.94 2/15/2024108,300 shares $2.89 million -49.0%1.1%0.7 $26.69 1/31/2024212,300 shares $6.35 million +272.5%1.4%1.3 $29.90 1/15/202457,000 shares $1.61 million +88.1%0.5%0.4 $28.28 12/31/202330,300 shares $849.92 thousand -2.6%0.3%0.3 $28.05 12/15/202331,100 shares $807.67 thousand +93.2%0.3%0.3 $25.97BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad)With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.Claim your free copy of “How to Survive the Next Financial Crisis” today 11/30/202316,100 shares $277.08 thousand +101.3%0.1%0.2 $17.21 11/15/20238,000 shares $131.20 thousand -11.1%0.1%0.2 $16.40 10/31/20239,000 shares $153.09 thousand -28.0%0.1%0.2 $17.01 10/15/202312,500 shares $236.25 thousand -20.9%0.1%0.3 $18.90 9/30/202315,800 shares $329.75 thousand +4.0%0.1%0.3 $20.87 9/15/202315,200 shares $307.80 thousand -22.1%0.1%0.2 $20.25 8/31/202319,500 shares $399.75 thousand +20.4%0.2%0.3 $20.50 8/15/202316,200 shares $324 thousand +8.7%0.2%0.3 $20.00 7/31/202314,900 shares $253.30 thousand +13.7%0.2%0.3 $17.00 7/15/202313,100 shares $204.49 thousand -30.7%0.1%0.3 $15.61 6/30/202318,900 shares $296.92 thousand -47.7%0.2%0.6 $15.71 6/15/202336,100 shares $403.24 thousand -44.4%0.3%1.2 $11.17 5/31/202364,900 shares $554.90 thousand +0.9%0.5%6.3 $8.55 5/15/202364,300 shares $520.83 thousand No Change0.5%4.6 $8.10 7/31/202211,600 shares $253.40 thousand -30.1%0.1%0.7 $21.85 7/15/202216,600 shares $371.67 thousand -37.4%0.1%0.6 $22.39 6/30/202226,500 shares $585.65 thousand -42.0%0.2%1.1 $22.10 6/15/202245,700 shares $970.21 thousand -11.8%0.3%1.9 $21.23 5/31/202251,800 shares $932.09 thousand -5.7%0.3%2.7 $17.99 5/15/202254,900 shares $947.03 thousand -0.7%0.3%3.9 $17.25 4/30/202255,300 shares $945.08 thousand -4.0%0.3%3.8 $17.09 4/15/202257,600 shares $1.01 million +9.1%0.3%3.7 $17.61 3/31/202252,800 shares $957.79 thousand -8.3%0.3%7 $18.14 3/15/202257,600 shares $998.78 thousand -12.3%0.3%7.3 $17.34 2/28/202265,700 shares $1.12 million +2.8%0.4%7.6 $17.10 2/15/202263,900 shares $1.17 million -3.6%0.4%8.3 $18.25 1/31/202266,300 shares $1.14 million -5.7%0.4%8.4 $17.19 1/15/202270,300 shares $1.26 million -5.4%0.3%3.4 $17.98 12/31/202174,300 shares $1.07 million +3.1%N/A3.7 $14.39 12/15/202172,100 shares $1.08 million +2.4%0.4%3.7 $15.00 11/30/202170,400 shares $1.04 million +2.9%0.3%3.5 $14.71 11/15/202168,400 shares $1.09 million -74.8%0.3%2.5 $15.90 10/29/2021271,000 shares $4.72 million +274.3%1.3%9.4 $17.43 10/15/202172,400 shares $1.14 million +0.4%0.4%3 $15.80 9/30/202172,100 shares $1.28 million -1.2%0.4%2.9 $17.73 9/15/202173,000 shares $1.27 million -1.6%0.4%2.7 $17.44 8/31/202174,200 shares $1.50 million -35.5%0.4%2.7 $20.19 8/13/2021115,000 shares $1.90 million No Change0.6%5.4 $16.53 PHVS Short Interest - Frequently Asked Questions What is Pharvaris' current short interest? Short interest is the volume of Pharvaris shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 446,000 shares of PHVS short. 1.98% of Pharvaris' shares are currently sold short. Learn More on Pharvaris' current short interest. What is a good short interest ratio for Pharvaris? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PHVS shares currently have a short interest ratio of 4.0. Learn More on Pharvaris's short interest ratio. What is a good short interest percentage for Pharvaris? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.98% of Pharvaris' floating shares are currently sold short. Is Pharvaris' short interest increasing or decreasing? Pharvaris saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 446,000 shares, a decline of 45.6% from the previous total of 819,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Pharvaris' float size? Pharvaris currently has issued a total of 52,290,000 shares. Some of Pharvaris' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Pharvaris currently has a public float of 22,560,000 shares. How does Pharvaris' short interest compare to its competitors? 1.98% of Pharvaris' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Pharvaris: ACADIA Pharmaceuticals Inc. (8.89%), Cytokinetics, Incorporated (13.26%), Akero Therapeutics, Inc. (10.92%), Krystal Biotech, Inc. (13.61%), ADMA Biologics Inc (5.96%), Lantheus Holdings, Inc. (12.75%), Arcellx, Inc. (16.18%), Zai Lab Limited Unsponsored ADR (4.33%), Vaxcyte, Inc. (10.57%), PTC Therapeutics, Inc. (8.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Pharvaris stock? Short selling PHVS is an investing strategy that aims to generate trading profit from Pharvaris as its price is falling. PHVS shares are trading up $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pharvaris? A short squeeze for Pharvaris occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PHVS, which in turn drives the price of the stock up even further. How often is Pharvaris' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHVS, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies ACAD Short Squeeze CYTK Short Squeeze AKRO Short Squeeze KRYS Short Squeeze ADMA Short Squeeze LNTH Short Squeeze ACLX Short Squeeze ZLAB Short Squeeze PCVX Short Squeeze PTCT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PHVS) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharvaris N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharvaris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access